Cascadian Therapeutics Inc (CASC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-1997 | 09-1997 | 06-1997 | 03-1997 | 12-1996 | |
| Sales | 2,402 | 2,318 | 2,858 | 1,971 | 2,339 |
| Gross Profit | 2,402 | 2,318 | 2,858 | 1,971 | 2,339 |
| Operating Income | 2,402 | 2,318 | 2,858 | 1,971 | 2,339 |
| Pre-tax Income | 2,402 | 2,318 | 2,858 | 1,971 | 2,339 |
| Net Income Continuous | -5,040 | -3,160 | -2,795 | -3,493 | -4,103 |
| Net Income | $-5,040 | $-3,160 | $-2,795 | $-3,493 | $-4,103 |
| EPS Basic Total Ops | -3.96 | -2.52 | -2.16 | -2.88 | -3.96 |
| EPS Basic Continuous Ops | -4.09 | -2.59 | -2.27 | -2.84 | -3.89 |
| EPS Diluted Total Ops | -3.96 | -2.52 | -2.16 | -2.88 | -3.96 |
| EPS Diluted Continuous Ops | -4.09 | -2.59 | -2.27 | -2.84 | -3.89 |
| EBITDA(a) | $2,402 | $2,318 | $2,858 | $1,971 | $2,339 |